Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma.

Pathology oncology research : POR - 1 Jul 2016

Zhao Jie, Chen Jiang, Lin Hui, Jin Renan, Liu Jinghua, Liu Xiaolong, Meng Ning, Cai Xiujun

Abstract excerpt

Hepatocellular carcinoma (HCC) is one of the most common and lethal human cancers. Recently, exome sequencing has revealed that mutation of ARID1A is frequent in HCC. Herein, we determined the clinicopathologic significance of ARID1A expression in HCC. We detected the level of mRNA and protein expression of ARID1A in 12 paired HCC tumors and adjacent non-cancerous tissues by quantitative real-time PCR and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Binding Proteins

Share to Gene Expression Regulation, Neoplastic

Share to Immunohistochemistry

Share to Kaplan-Meier Estimate

Share to Liver Neoplasms

Share to Nuclear Proteins

Source

Identifiers

PMID: 26589513
DOI: 10.1007/s12253-015-0022-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma.PMID 26589513Read ↗

Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinomaSemantic proximity Read ↗

Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular CarcinomaSemantic proximity Read ↗

Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular CarcinomaSemantic proximity Read ↗

ARID2: a new tumor suppressor gene in hepatocellular carcinoma.Semantic proximity Read ↗

Effect of ARID1A mutation and expression on prognosis of hepatocellular carcinoma and cholangiocarcinoma: a meta-analysisSemantic proximity Read ↗

ARID1A alterations and their clinical significance in cholangiocarcinomaSemantic proximity Read ↗

ARID1A mutation is associated with an immunosuppressive microenvironment and poor prognosis in hepatocellular carcinoma: An integrated bioinformatics analysis.Semantic proximity Read ↗

ARID1A Upregulation Predicts Poor Survival in Patients With Liver Cancer Semantic proximity Read ↗

Loss of cBAF Complex Confers Sorafenib Resistance in Liver CancerSemantic proximity Read ↗

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.Semantic proximity Read ↗

Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients.Semantic proximity Read ↗

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.